The Global. In the decade that will decide the leadership in the field of biosimilars, the general director of Sandoz in Spain, Joaquín Rodrigo, explains the work that he carries out in the Novartis subsidiary.
recently published
Horizon scanning
Jan 31 2024
Early Treatment: the role of biosimilars
18 2023 December
